Takeda Pharmaceutical logo
Takeda Pharmaceutical
TKPHF | OTC
Chart Builder DCF Calculator
$36.77
+$0.02 (+0.05%)
At close: Oct 2, 2026, 3:04 PM ET

Takeda Pharmaceutical Company Profile

Company profile explained

Company Profile

Takeda Pharmaceutical Company Limited, an established global biopharmaceutical entity founded in 1781 and based in Tokyo, Japan, is comprehensively involved in the entire process of bringing new medicines to market. This includes the research, development, production, commercialization, and external licensing of its pharmaceutical products across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and other parts of Asia. The company concentrates its therapeutic endeavors on key medical areas such as digestive health (gastroenterology), rare disorders, treatments derived from blood plasma, cancer care (oncology), and neurological conditions. Its extensive portfolio features numerous well-known brands, including Entyvio, Takhzyro, Velcade, Livtencity, and Dexilant, among others. Takeda actively cultivates a wide-ranging network of strategic partnerships and collaborations. This includes out-licensing agreements, for example with Neurocrine Biosciences, Inc.; in-licensing deals and research collaborations with organizations like the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and joint research efforts with companies such as Crescendo Biologics and Skyhawk Therapeutics. Furthermore, Takeda maintains strategic alliances with entities like Evotec SE and KSQ Therapeutics, underscoring its commitment to external innovation.

Key Executives

Name Position
Julie Kim CEO, President & Director
Michael Fox Chief Operating Officer
Milano Furuta Chief Financial Officer & Director
Andrew S. Plump President of Research & Development and Representative Director
Gabriele Ricci Chief Data & Technology Officer
Haruhiko Hirate Member of Management Board
Iwaaki Taniguchi Senior Vice President of Corporate Finance & Controlling Department
Norimasa Takeda Chief Accounting Officer & Corporate Controller
Salvatore Alesci Member of Management Board and Head of R&D Global Science & Biomedical Policy
Seigo Izumo Chair of Management Board
Takeda Pharmaceutical
Takeda Pharmaceutical logo
Country Japan
IPO Date Jun 25, 2008
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 47,029
CEO Julie So-Young Kim

Contact Details

1-1, Nihonbashi-Honcho 2-chome Tokyo, OS 103-8668 Japan

Stock Details

Ticker Symbol TKPHF
Exchange OTC
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001395064
CUSIP Number n/a
ISIN Number JP3463000004
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.